Literature DB >> 6267753

The Epstein-Barr virus (EBV) in the pathogenesis of posttransplant lymphoma.

D W Hanto, G Frizzera, J Gajl-Peczalska, D T Purtilo, G Klein, R L Simmons, J S Najarian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6267753

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Cancer after transplantation.

Authors:  A G Sheil
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

2.  Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.

Authors:  J G Garner; M S Hirsch; R T Schooley
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

Authors:  D W Hanto; K J Gajl-Peczalska; G Frizzera; D C Arthur; H H Balfour; K McClain; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

4.  The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus disease.

Authors:  Heather E Vezina; Richard C Brundage; Thomas E Nevins; Henry H Balfour
Journal:  Clin Pharmacol       Date:  2009-12-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.